MWM
TEVA icon

Mascoma Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Mascoma Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-80
Closed -$1K – 418
2018
Q4 		$1K Hold
80
– – ﹤0.01% 363
2018
Q3 		$2K Hold
80
– – ﹤0.01% 369
2018
Q2 		$2K Hold
80
– – ﹤0.01% 367
2018
Q1 		$1K Hold
80
– – ﹤0.01% 365
2017
Q4 		$2K Sell
80
-87
-52% -$1.31K ﹤0.01% 348
2017
Q3 		$3K Hold
167
– – ﹤0.01% 352
2017
Q2 		$6K Sell
167
-200
-54% -$6.19K ﹤0.01% 317
2017
Q1 		$12K Sell
367
-404
-52% -$13.8K 0.01% 250
2016
Q4 		$28K Buy
+771
New +$30.8K 0.02% 186

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return